These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34208117)

  • 1. Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update.
    Chen S; Chun KRJ; Ling Z; Liu S; Zhu L; Wang J; Schratter A; Acou WJ; Kiuchi MG; Yin Y; Schmidt B
    J Cardiovasc Dev Dis; 2021 Jun; 8(6):. PubMed ID: 34208117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes of left atrial appendage occlusion versus direct oral anticoagulation in patients with atrial fibrillation and prior ischemic stroke: A propensity-score matched study.
    Korsholm K; Valentin JB; Damgaard D; Diener HC; Camm AJ; Landmesser U; Hildick-Smith D; Johnsen SP; Nielsen-Kudsk JE
    Int J Cardiol; 2022 Sep; 363():56-63. PubMed ID: 35780932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk.
    Godino C; Melillo F; Bellini B; Mazzucca M; Pivato CA; Rubino F; Figini F; Mazzone P; Della Bella P; Margonato A; Colombo A; Montorfano M
    EuroIntervention; 2020 Apr; 15(17):1548-1554. PubMed ID: 31845892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation.
    Nielsen-Kudsk JE; Korsholm K; Damgaard D; Valentin JB; Diener HC; Camm AJ; Johnsen SP
    JACC Cardiovasc Interv; 2021 Jan; 14(1):69-78. PubMed ID: 33413867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
    Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
    Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study.
    Waranugraha Y; Lin LY; Tsai CT
    Trends Cardiovasc Med; 2024 May; 34(4):225-233. PubMed ID: 36775218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies.
    Li X; Wen SN; Li SN; Bai R; Liu N; Feng L; Ruan YF; Du X; Dong JZ; Ma CS
    Heart Rhythm; 2016 Jun; 13(6):1203-14. PubMed ID: 26724488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of cardiac surgery with left atrial appendage occlusion versus no Occlusion, direct oral Anticoagulants, and vitamin K Antagonists: A systematic review with Meta-analysis.
    Nso N; Nassar M; Zirkiyeva M; Lakhdar S; Shaukat T; Guzman L; Alshamam M; Foster A; Bhangal R; Badejoko S; Lyonga Ngonge A; Tabot-Tabot M; Mbome Y; Rizzo V; Munira MS; Thambidorai S
    Int J Cardiol Heart Vasc; 2022 Jun; 40():100998. PubMed ID: 35655531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke.
    Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L
    Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 34187638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-vitamin K antagonist oral anticoagulation versus left atrial appendage occlusion for primary and secondary stroke prevention after cardioembolic stroke.
    Paiva L; Coelho J; Barra S; Costa M; Sargento-Freitas J; Cunha L; Gonçalves L
    Rev Port Cardiol (Engl Ed); 2021 May; 40(5):357-365. PubMed ID: 33858727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the CHA
    Agudelo V; Millán X; Li CH; Asmarats L; Fernández-Peregrina E; Santaló M; Jimenez-Kockar M; Gheorghe L; Serra A; Arzamendi D
    Int J Cardiol; 2020 Nov; 319():78-84. PubMed ID: 32634500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation-One-Year Survival.
    Tiosano S; Banai A; Mulla W; Goldenberg I; Bayshtok G; Amit U; Shlomo N; Nof E; Rosso R; Glikson M; Guetta V; Barbash I; Beinart R
    J Clin Med; 2023 Oct; 12(20):. PubMed ID: 37892833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct oral anticoagulants versus percutaneous left atrial appendage occlusion in atrial fibrillation: 5-year outcomes.
    Melillo F; Leo G; Parlati ALM; Gaspardone C; Bellini B; Della Bella P; Montorfano M; Mazzone P; Nemola G; Cozzani G; Stella S; Ancona F; Ingallina G; Salerno A; Cera M; Agricola E; Margonato A; Godino C
    Int J Cardiol; 2023 Oct; 389():131188. PubMed ID: 37453454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of anticoagulation following left atrial appendage occlusion with the LARIAT device in patients with nonvalvular atrial fibrillation: impact on thromboembolism, bleeding and mortality. Real life data.
    Litwinowicz R; Filip G; Sobczyk D; Lakkireddy D; Vuddanda VLK; Bartuś M; Kapelak B; Bartuś K
    Postepy Kardiol Interwencyjnej; 2020 Mar; 16(1):89-96. PubMed ID: 32368241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of successful left atrial appendage occlusion with focus on stroke prevention: 10-year follow-up of a single-center registry.
    Maarse M; Aarnink EW; Huijboom MFM; Abeln BGS; Staal D; Rensing BJWM; Kerklaan JP; van Dijk VF; Swaans MJ; Boersma LVA
    Heart Rhythm O2; 2023 May; 4(5):298-308. PubMed ID: 37323993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally invasive left atrial appendage occlusion plus reduced dose direct oral anticoagulant to prevent stroke in patients with atrial fibrillation-the LAAO-PlusRE.
    Besola L; Gregori D; Fiocco A; Colli A
    Ann Cardiothorac Surg; 2024 Mar; 13(2):146-154. PubMed ID: 38590988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation.
    Maarse M; Seiffge DJ; Werring DJ; Boersma LVA; ; ; Aarnink EW; Fierro N; Mazzone P; Beneduce A; Tondo C; Gasperetti A; Pracon R; Demkow M; Zielinski K; de Backer O; Korsholm K; Nielsen-Kudsk JE; Estévez-Loureiro R; Caneiro-Queija B; Benito-González T; de Prado AP; Nombela-Franco L; Salinas P; Holmes D; Almakadma AH; Berti S; Romeo MR; Alvarez XM; Arzamendi D; Alla VM; Agarwal H; Eitel I; Paitazoglou C; Freixa X; Cepas-Guillén P; Chothia R; Badejoko SO; Bergmann MW; Spoon DB; Maddux JT; El-Chami M; Ram P; Branca L; Adamo M; Suradi HS; van Dijk VF; Rensing BJWM; Zietz A; Paciaroni M; Caso V; Koga M; Toyoda K; Kallmünzer B; Cappellari M; Wilson D; Engelter S; Swaans MJ;
    JAMA Neurol; 2024 Sep; 81(11):1150-8. PubMed ID: 39374446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
    Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
    Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.